172 related articles for article (PubMed ID: 28214902)
1. Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.
Solid CA; Peter SA; Natwick T; Guo H; Collins AJ; Arduino JM
Nephron; 2017; 136(2):54-61. PubMed ID: 28214902
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.
St Peter WL; Guo H; Kabadi S; Gilbertson DT; Peng Y; Pendergraft T; Li S
BMC Nephrol; 2018 Mar; 19(1):67. PubMed ID: 29544446
[TBL] [Abstract][Full Text] [Related]
3. Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.
Gagnon-Sanschagrin P; Liang Y; Sanon M; Oberdhan D; Guérin A; Cloutier M
J Med Econ; 2021; 24(1):193-201. PubMed ID: 33464936
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource use and costs associated with chronic kidney disease in US private insurance patients with multiple myeloma.
Bhowmik D; Song X; Intorcia M; Kent ST; Shi N
J Oncol Pharm Pract; 2019 Jun; 25(4):855-864. PubMed ID: 29661050
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population.
Grabner M; Bodhani A; Khandelwal N; Palli S; Bonine N; Khera M
J Sex Med; 2017 Jan; 14(1):88-97. PubMed ID: 27939338
[TBL] [Abstract][Full Text] [Related]
7. Economic burden associated with patients diagnosed with hepatitis C.
McCombs JS; Yuan Y; Shin J; Saab S
Clin Ther; 2011 Sep; 33(9):1268-80. PubMed ID: 21840056
[TBL] [Abstract][Full Text] [Related]
8. Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA.
Gallant J; Hsue P; Budd D; Meyer N
Curr Med Res Opin; 2018 Jan; 34(1):13-23. PubMed ID: 28933204
[TBL] [Abstract][Full Text] [Related]
9. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
10. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
11. Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients.
Wetmore JB; Peng Y; Jackson S; Matlon TJ; Collins AJ; Gilbertson DT
Clin Nephrol; 2016 Feb; 85(2):101-11. PubMed ID: 26636331
[TBL] [Abstract][Full Text] [Related]
12. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
13. A population-based cohort study defines prognoses in severe chronic kidney disease.
Tonelli M; Wiebe N; James MT; Klarenbach SW; Manns BJ; Ravani P; Strippoli GFM; Hemmelgarn BR;
Kidney Int; 2018 May; 93(5):1217-1226. PubMed ID: 29525394
[TBL] [Abstract][Full Text] [Related]
14. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis.
Liao M; Li Y; Kianifard F; Obi E; Arcona S
BMC Nephrol; 2016 Mar; 17():25. PubMed ID: 26936756
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
[TBL] [Abstract][Full Text] [Related]
16. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
Patel AR; Dombrovskiy VY; Vogel TR
Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
[TBL] [Abstract][Full Text] [Related]
17. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
Mitwalli AH; Hayat A; Alwakeel J; Hammad D
Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
[TBL] [Abstract][Full Text] [Related]
18. All-cause costs increase exponentially with increased chronic kidney disease stage.
Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
20. Comparative Outcomes of Carotid Artery Stent Placement and Carotid Endarterectomy in Patients with Chronic Kidney Disease and End-Stage Renal Disease.
Adil MM; Saeed F; Chaudhary SA; Malik A; Qureshi AI
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1721-1727. PubMed ID: 27085817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
